J. Jarboe

Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study.

J. Sosman, I. Puzanov, A. Santoro, 2012 .

Incidence and Evaluation of Incidental Abnormal Bone Marrow Signal on Magnetic Resonance Imaging

G. Shah, A. Klein, A. Rosenberg, 2014, TheScientificWorldJournal.

Gallium-67 imaging in lymphoma: tricks of the trade.

K. Morton, K A Morton, J Jarboe, 2000, Journal of nuclear medicine technology.

First line therapy for metastatic pancreatic cancer.

M. Saif, J. Jarboe, 2013, JOP : Journal of the pancreas.

Highlights on the first line treatment of metastatic pancreatic cancer.

M. Saif, K. Gunturu, J. Jarboe, 2012, JOP : Journal of the pancreas.

Therapeutic human monoclonal antibodies against cancer.

W. Saif, J. Jarboe, Anumeha Gupta, 2014, Methods in molecular biology.

Efficacy in selected tumor types in a phase I study of the c-MET inhibitor ARQ 197 in combination with sorafenib.

J. Sosman, I. Puzanov, A. Adjei, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.